Cerus Corporation
NASDAQ:CERSMedical - Devices
+$0.08 today
- Market cap
- $391.79M
- Beta
- 1.77
- P/E (TTM)
- -53.8
- EPS (TTM)
- -$0.05
Volume 6.09M
Average 2.33M
CERS Inventory
Cash effect of the change in inventory; building inventory consumes cash.
Cerus CorporationNASDAQ: CERS
Inventory · Q1 FY2026 · quarter ended Mar 2026
Inventory dips below year-ago levels
Q1 FY2026 inventory of $5.82M (cash outflow) fell 8.2% year over year, behind the +1479.0% change in trailing-twelve-month inventory. Sequentially, it rose 83.1% from the prior quarter. Over 3 fiscal years it compounded at +102.5% a year.
Context
- Inventory amounted to 7.1% of revenue in FY2025, up 3.2 pp from a year earlier.
- Inventory increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -8.2% toward the trailing-twelve-month pace of +1479.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Inventory history
USD · from the cash flow
- Latest · FY2025
- (14.68M) USD
- Year-over-year change
- -308.8%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (14.68M) | -308.8% |
| FY2024 | 2024-12-31 | 7.03M | +147.0% |
| FY2023 | 2023-12-31 | (14.95M) | -745.4% |
| FY2022 | 2022-12-31 | (1.77M) | +91.0% |
| FY2021 | 2021-12-31 | (19.61M) | — |
Inventory vs competitors
How CERS compares with its peers on the latest reported figures
- Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1479.0% is the highest of 4, against a peer median of +280.2%.
- Inventory amounts to 6.4% of revenue for CERS, versus a peer median of 3.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | €191.78M EUR | -385.1% | -46.3% | 2.6% | |
| LTM Jun 2026 | $47.85M USD | +310.6% | -2.1% | 9.3% | |
| LTM Jun 2026 | $43.06M USD | +280.2% | +15.5% | 3.2% | |
| LTM Mar 2026 | $14.16M USD | +1479.0% | +102.5% | 6.4% | |
| Peer median (excluding CERS) | — | +280.2% | -2.1% | 3.2% | |
Competitors are the stored peer set for CERS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (54.38M) | (42.83M) | (37.49M) | (20.96M) | (15.63M) |
| Depreciation & Amortization | 3.15M | 2.98M | 2.6M | 1.86M | 1.86M |
| Deferred Income Tax | 462K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 23.57M | 24.46M | 20.27M | 22.87M | 22.87M |
| Change in Working Capital | (9.4M) | (16.05M) | (32.04M) | 5.23M | (6.83M) |
| Accounts Receivables | (4.22M) | (9.2M) | (1.1M) | 5.5M | (396K) |
| Inventory | (19.61M) | (1.77M) | (14.95M) | 7.03M | (14.68M) |
| Accounts Payables | 12.2M | (4.91M) | (7.34M) | (1.48M) | 5.73M |
| Other Working Capital | 2.22M | (179K) | (8.65M) | (5.83M) | 2.52M |
| Other Non-Cash Items | 2.67M | 5.82M | 3.49M | 2.37M | 9.09M |
| Operating Cash Flow | (33.92M) | (25.62M) | (43.17M) | 11.36M | 11.36M |
| Capital Expenditures | (910K) | (2M) | (4.6M) | (2.84M) | (2.84M) |
| Acquisitions (Net) | 910K | (10.46M) | 0 | 0 | 0 |
| Purchases of Investments | (52.07M) | (29.64M) | (2.49M) | (42.98M) | (42.98M) |
| Sales of Investments | 65.66M | 40.1M | 15.71M | 37.68M | 37.68M |
| Other Investing Activities | (910K) | 10.46M | 0 | 0 | 0 |
| Investing Cash Flow | 12.69M | 8.46M | 8.62M | (8.13M) | (8.13M) |
| Debt Repayment | 21.18M | 212K | 9.92M | 4.3M | (329K) |
| Common Stock Issued | 2.74M | 0 | 0 | 0 | 560K |
| Common Stock Repurchased | 0 | (104K) | (175K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 10.37M | 4.08M | 925K | 667K | 4.73M |
| Financing Cash Flow | 34.29M | 4.19M | 10.67M | 4.96M | 4.96M |
| Effect of Forex Changes | (919K) | (727K) | (128K) | (191K) | (191K) |
| Net Change in Cash | 12.14M | (13.69M) | (24M) | 8M | 8M |
| Free Cash Flow | (34.83M) | (27.62M) | (47.77M) | 8.52M | 8.52M |
Cerus Corporation
NASDAQ:CERS
Intrinsic Alpha fair value
Locked
Current Price
$1.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.